论文部分内容阅读
肺心病是多脏器多功能损伤的疾病。肺和心脏是肺心病病理改变的中心环节。心肌酶谱的改变,对急性心肌梗塞(AMI)诊断和评估病情的意义已经明确,但对肺心病病情评估的意义,到目前为止尚未完全肯定,为此本文对75例肺心病作了系统观察。现将结果报告如下。资料和方法本文系1987年12月～1988年4月间,住院的75例肺心病患者。所观察的心肌酶谱包括谷草转氨酶(GOT)、谷丙转氨酶(GPT)、GOT/GPT(O/P)比值,磷酸肌酸激酶(CPK)、r—羟丁酸脱氢酶(HBD)。乳酸脱氢酶(LDH)、HBD/LPH(H/L)比值。同时观察的还有动脉血气、血清C—反应性蛋白以及血清镁钙等。全组病例均在病情急重期同步检测了上述项目,有70例患者在病情好转期复检了上述项目。
Pulmonary heart disease is a multi-organ multi-functional injury disease. Lung and heart is the heart of pulmonary heart disease pathological changes. The changes of myocardial enzymes, the significance of AMI diagnosis and assessment of the disease has been clear, but the significance of assessment of pulmonary heart disease has not yet been fully affirmed, for this reason 75 cases of pulmonary heart disease were observed . The results reported below. Materials and Methods This article is from December 1987 to April 1988, hospitalized 75 cases of pulmonary heart disease patients. The observed myocardial enzymes include aspartate aminotransferase (GOT), alanine aminotransferase (GPT), GOT / GPT (O / P) ratio, creatine phosphokinase (CPK) and r- hydroxybutyrate dehydrogenase (HBD). Lactate dehydrogenase (LDH), HBD / LPH (H / L) ratio. Also observed arterial blood gas, serum C-reactive protein and serum magnesium and calcium. All the patients in the critical condition of the disease simultaneously detected the above items, 70 patients in the condition is good for the re-examination of the above items.